Viatris Pharmaceuticals 401(k) match, vesting and fees

Plan year 2024 filingPfizer Pharmaceuticals LLC Profit Sharing Employee Savings Plan · Plan 011 · EIN 66-0577291Updated Oct 2026

What Viatris Pharmaceuticals' 401(k) plan says about matching contributions

The match terms have not been published from this plan's filing yet.
The plan year 2024 filing reports $7.2M in employer contributions, about $6,192 per participant. That total includes any match and profit-sharing; it is not a match formula. Plan year 2024 Form 5500 ↗
$57,444
Average account balance
1,511
Participants (end of year)
$66.9M
Plan assets (end of year)
0.03%
Admin expenses ÷ assets

Plan features

Match, vesting and enrollment details have not been published from this plan's audit report yet. The figures below come from the structured filing.

RecordkeeperMerrill Lynch, Pierce, Fenner and SSchedule C ↗
Independent auditorSchneider Downs (unmodified opinion, limited scope)Schedule H ↗
Plan type and status401(k) · ActiveForm 5500 ↗
Late participant contributionsReported on the filingSchedule H ↗

How the plan compares

Plan year 2024 medians for 1,622 defined-contribution plans in manufacturing with 1,000 to 4,999 participants.

Viatris Pharmaceuticals: employer contribution per participant$6,192
Peer median$2,413
Viatris Pharmaceuticals: average balance$57,444
Peer median$86,434
Viatris Pharmaceuticals: admin expenses ÷ assets0.03%
Peer median0.12%

Admin expenses are the plan's reported administrative expenses divided by its assets; they do not include fund expense ratios.

Plan history

Plan assets went from $51.1M at the end of plan year 2023 to $66.9M at the end of plan year 2024.

$51.1M2023$66.9M2024
End-of-year figures from each plan year's Form 5500 filing for the Viatris Pharmaceuticals plan.
Plan yearParticipantsAssetsEmployer contributionsPer participantAdmin expense ratioMatch formulaFiling
20241,511$66.9M$7.2M$6,1920.03%Not publishedForm 5500 ↗
20231,518$51.1M$7.7M$6,5620.00%Not publishedForm 5500 ↗

Other Viatris Pharmaceuticals plans (1)

Each plan files its own Form 5500. Figures are from each plan's latest filing.

Pfizer Consolidated Pension Plan for Employees Resident in Puerto Rico

Plan 004 · EIN 66-0577291 · plan year 2024 filing
$75,946
Average account balance
7,954
Participants (end of year)
$604M
Plan assets (end of year)
0.36%
Admin expenses ÷ assets

Plan features

Match, vesting and enrollment details have not been published from this plan's audit report yet. The figures below come from the structured filing.

RecordkeeperFidelitySchedule C ↗
Independent auditorSchneider Downs & Co. Inc. (unmodified opinion, limited scope)Schedule H ↗
Plan type and statusPension (defined benefit) · ActiveForm 5500 ↗

Common questions

Does Viatris Pharmaceuticals match 401(k) contributions?

The match terms for the Pfizer Pharmaceuticals LLC Profit Sharing Employee Savings Plan have not been published from its filing yet. The plan year 2024 filing reports $7.2M in employer contributions, about $6,192 per participant. That total includes any match and profit-sharing; it is not a match formula.

When is the Viatris Pharmaceuticals 401(k) match vested?

The vesting schedule for the Pfizer Pharmaceuticals LLC Profit Sharing Employee Savings Plan is not in the data published so far. Your Summary Plan Description states it.

Who manages the Viatris Pharmaceuticals 401(k)?

The recordkeeper listed on Schedule C of the plan year 2024 filing is Merrill Lynch, Pierce, Fenner and S. The plan administrator is Pfizer Pharmaceuticals LLC.

I left Viatris Pharmaceuticals. How do I find my old 401(k)?

Your account stays in the plan until you move it. Contact the plan administrator (Pfizer Pharmaceuticals LLC, (724) 514-1800) or the recordkeeper, Merrill Lynch, Pierce, Fenner and S. The Viatris Pharmaceuticals old 401(k) page lists the contacts from every plan filing. Find an old Viatris Pharmaceuticals 401(k)

Data from the public Form 5500 annual reports Viatris Pharmaceuticals filed with the U.S. Department of Labor (plan years 2023 and 2024) and, where noted, the attached independent auditor's report. Plan terms may have changed since the filing; check your current Summary Plan Description. PlanFacts is not affiliated with Viatris Pharmaceuticals. Not financial advice. Report a correction · Methodology